LGBMSep 20, 2023

Large-scale Pretraining Improves Sample Efficiency of Active Learning based Molecule Virtual Screening

arXiv:2309.11687v12 citationsh-index: 4
Originality Incremental advance
AI Analysis

This work addresses the computational inefficiency of screening ultra-large compound libraries in drug discovery, offering a significant but incremental improvement in sample efficiency.

The study tackled the problem of virtual screening in drug discovery by using pretrained transformer and graph neural network models within a Bayesian optimization active learning framework, resulting in identifying 58.97% of top-50,000 compounds after screening only 0.6% of a 99.5 million compound library, an 8% improvement over previous state-of-the-art.

Virtual screening of large compound libraries to identify potential hit candidates is one of the earliest steps in drug discovery. As the size of commercially available compound collections grows exponentially to the scale of billions, brute-force virtual screening using traditional tools such as docking becomes infeasible in terms of time and computational resources. Active learning and Bayesian optimization has recently been proven as effective methods of narrowing down the search space. An essential component in those methods is a surrogate machine learning model that is trained with a small subset of the library to predict the desired properties of compounds. Accurate model can achieve high sample efficiency by finding the most promising compounds with only a fraction of the whole library being virtually screened. In this study, we examined the performance of pretrained transformer-based language model and graph neural network in Bayesian optimization active learning framework. The best pretrained models identifies 58.97% of the top-50000 by docking score after screening only 0.6% of an ultra-large library containing 99.5 million compounds, improving 8% over previous state-of-the-art baseline. Through extensive benchmarks, we show that the superior performance of pretrained models persists in both structure-based and ligand-based drug discovery. Such model can serve as a boost to the accuracy and sample efficiency of active learning based molecule virtual screening.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes